Ruitong Bio Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 4

Ruitong Bio General Information

Description

Developer and provider of ophthalmic degradable long-acting sustained-release technology designed to address the challenge of frequent eye drop administration. The company offers advanced drug delivery systems, enabling medical and veterinary users with long-duration release solutions for ocular care.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • A903-A906, Building 1, Phase II, Yinxing Zhijie, No. 1301-76, Guanguang Road
  • Xinlan Community, Guanlan Street, Longhua District
  • Shenzhen, Guangdong
  • China
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Drug Delivery
Corporate Office
  • A903-A906, Building 1, Phase II, Yinxing Zhijie, No. 1301-76, Guanguang Road
  • Xinlan Community, Guanlan Street, Longhua District
  • Shenzhen, Guangdong
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ruitong Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 20-Jan-2025 Completed Product Development
To view Ruitong Bio’s complete valuation and funding history, request access »

Ruitong Bio Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Dalton Venture Venture Capital Minority
Jenkem Technology Corporation Minority
National Innovation Center for Advanced Medical Devices Corporation Minority
Triwise Capital Venture Capital Minority
To view Ruitong Bio’s complete investors history, request access »

Ready to get started?

Request a free trial

Ruitong Bio FAQs

  • When was Ruitong Bio founded?

    Ruitong Bio was founded in 2021.

  • Where is Ruitong Bio headquartered?

    Ruitong Bio is headquartered in Shenzhen, China.

  • What industry is Ruitong Bio in?

    Ruitong Bio’s primary industry is Drug Discovery.

  • Is Ruitong Bio a private or public company?

    Ruitong Bio is a Private company.

  • What is Ruitong Bio’s current revenue?

    The current revenue for Ruitong Bio is .

  • Who are Ruitong Bio’s investors?

    Dalton Venture, Jenkem Technology, National Innovation Center for Advanced Medical Devices, and Triwise Capital have invested in Ruitong Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process